Dr. Sundaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Icahn School of Medicine at Mount Sinai
1425 Madison Ave
New York, NY 10029
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Cleveland Clinic FoundationResidency, Internal Medicine, 2012 - 2015
L. Tilak Municipal Medical CollegeClass of 2011
Certifications & Licensure
NY State Medical License 2018 - 2025
OH State Medical License 2012 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL Start of enrollment: 2021 Feb 19
Roles: Principal Investigator, Contact
- Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas Start of enrollment: 2018 Mar 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia.Kevin G Zablonski, Sydney A Skupa, Alexandria P Eiken, Suchitra Sundaram, Cory Mavis
Leukemia & Lymphoma. 2024-12-01 - High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.Narendranath Epperla, Adam S Zayac, Daniel J Landsburg, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2024-10-22 - 7 citationsHigh-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.Adam S Zayac, Daniel J Landsburg, Mitchell E Hughes, Allison M Bock, Grzegorz S Nowakowski
Blood Advances. 2023-11-14
Abstracts/Posters
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Ce...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
R2 Maintenance for Elderly MCL Patients Worth the Risk?December 13th, 2021- Venetoclax Regimens for 'Fit' CLL Yield High Undetectable MRD RatesDecember 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
